Skip to content

Public FDA record

Z-2337-2024: The VASOVIEW HEMOPRO Endoscopic Vessel Harvesting Systems is designed for use in conjunction with the 7 m

Recall record Z-2337-2024 for Maquet Cardiovascular, LLC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2337-2024
Company in FDA record
Maquet Cardiovascular, LLC
FDA classification date
Jul 11, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

There were 27 complaints between March 22, 2024, and April 30, 2024, related to VH-3500 and VH-4000, reporting that the C-Ring wire was straightened (due to insufficient bend radius) and that the distance between C-Ring and Harvesting Tool was closer than normal. No adverse events have been reported to date in direct association with this issue.

Source facts

Action
Maquet Cardiovascular, LLC (MCV), a subsidiary of Getinge issued Urgent Medical Device Removal Letter to consignees via FedEx 2-Day Delivery with Signature Proof of Delivery (SPOD) on 31 May 2024. Letter states reason for recall, health risk and action to take: Please examine your inventory immediately to determine if you have any of the HemoPro devices with the product code/lot number(s) listed in this notice. " Prior to use, always refer to Instructions for Use, Section Warning and Precautions , specifically: o HemoPro 2 Always advance the C-Ring and Harvesting Tool under endoscopic visualization. Ensure adequate visualization of the HEMOPRO 2 Jaws and the surgical site prior to application of electrosurgical energy. If visualization of the surgical site is impaired, do not initiate or continue activation of energy to the HEMOPRO 2 Jaws to avoid thermal injury to tissue. o HemoPro: Always advance the C-Ring and Harvesting Tool under endoscopic visualization. CAUTION: Take care to avoid engaging the components of the C-Ring assembly with the VASOVIEW HEMOPRO jaws. Doing so may damage portions of the C-Ring assembly causing the components to separate from the assembly and fall into the body. " Should you have any affected product as listed in this notification, do not use the product and remove it from areas of use. You will receive credit upon the return of any affected devices. " Please forward this information to all current and potential HemoPro and HemoPro 2 users within your hospital / facility. " If you are a distributor who has shipped any affected product(s) to customers, please forward this document to their attention for appropriate action. " Please contact Getinge Customer Service at 888-880-2874 between 6:00 a.m. and 5:00 p.m. Pacific Standard Time to request a return material authorization (RMA) and shipping instructions to return any affected product. Pack the product to be returned with the appropriate return documents and, using the shipping
Initiated
2024-05-31
Root cause
Under Investigation by firm
Distribution
NationwideForeign: AT DE DK ES GB HK IT NL ZA
Recall number
Z-2337-2024
Recall status
Open, Classified
CDRH record ID
208372
FDA classified
2024-07-11
Recall event number
94802

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗